Business
MCAP: Achieved SEK 1,807 million revenue in 2024 with a 23% EBITA CAGR, driven by acquisitions
MCAP: Achieved SEK 1,807 million revenue in 2024 with a 23% EBITA CAGR, driven by acquisitions
About this update from Medcap Ab
With a focus on life science, the group has achieved strong growth, reaching SEK 1,807 million in 2024 revenue and a 23% EBITA CAGR over five years. Its buy & build strategy targets scalable, profitable companies in non-cyclical, demographically driven markets.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.